EPICC study: Evaluation of pharmaceutical intervention in cancer care

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 2, 2015, Pages 196-203

  Vantard, N ^a   Ranchon, F ^a,b   Schwiertz, V ^a   Gourc, C ^a   Gauthier, N ^a   Guedat, M G ^a   He, S ^a   Kiouris, E ^a   Alloux, C ^a   You, B ^a,b   Souquet, P J ^a   Freyer, G ^a,b   Salles, G ^a,c   Trillet Lenoir, V ^a   Rioufol, C ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

cancer care; clinical pharmacy in oncology; drug related problems; pharmaceutical intervention

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; PACLITAXEL;

ACT IP; ANTIBIOTIC THERAPY; ARTICLE; CANCER THERAPY; CLINICAL EFFECTIVENESS; CODING; COMPUTER PROGRAM; DATA ANALYSIS; DECISION TREE; DOSE CALCULATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MEDICAL SOCIETY; MEDICATION ERROR; NEOPLASM; ONCOLOGY; ONLINE SYSTEM; PATIENT CARE; PATIENT SAFETY; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; DOSE RESPONSE; DRUG INTERACTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITAL BED CAPACITY; HOSPITAL PHARMACY; MALE; NEOPLASMS; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL;

ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, TEACHING; HUMANS; MALE; MEDICATION ERRORS; NEOPLASMS; PHARMACY SERVICE, HOSPITAL;

EID: 84924096885     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12242     Document Type: Article

References (56)

1. Brennan TA, Leape LL, Laird NM, et al,. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. Qual Saf Health Care, 2004; 13: 145-151.
2. Bates DW, Cullen DJ, Laird N, et al,. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA, 1995; 274: 29-34.
3. Viktil KK, Blix HS,. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol, 2008; 102: 275-280.
4. Buurma H, De Smet P, Leufkens H, Egberts A,. Evaluation of the clinical value of pharmacists' modifications of prescription errors. Br J Clin Pharmacol, 2004; 58: 203-511.
5. Lu CY, Ross-Degnan D, Soumerai ST, Pearson S,. Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature 2001-2007. BMC Health Serv Res, 2008; 8: 75.
6. Song L, Chui WC, Lau CP, Cheung BM,. A 3-year study of medication incidents in an acute general hospital. J Clin Pharm Ther, 2008; 33: 109-114.
7. Bedouch P, Tessier A, Baudrant M, et al,. Computerized physician order entry system combined with on-ward pharmacist: analysis of pharmacists' interventions. J Eval Clin Pract, 2012; 18: 911-918.
8. Khalili H, Farsaei S, Rezaee H, Dashti-Khavidaki S,. Role of clinical pharmacists' interventions in detection and prevention of medication errors in a medical ward. Int J Clin Pharm, 2011; 33: 281-284.
9. Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, Wu SC,. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr, 2012; 54: 168-174.
10. Westerlund T, Almarsdõttir AB, Melander A,. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci, 1999; 21: 245-250.
11. Schaefer M,. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci, 2002; 24: 120-127.
12. Meyboom RHB, Lindquist M, Egberts ACG,. An ABC of drug-related problems. Drug Saf, 2000; 22: 415-423.
13. ASHP guidelines on a standardized method for pharmaceutical care. In:, Deffenbaugh J, ed. Best practices for health-system pharmacy. Bethesda, MD: American Society of Health-System Pharmacists, 109-111, 1996.
14. Grupo de Investigacíon en Aténcion Farmacéutica. [The second Granada consensus on drug-related problems] Spanish. Ars Pharmaceutica, 2002; 43: 175-184.
15. Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, Cromarty J, A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract, 2002; 10: 91-100.
16. Pharmaceutical Care Network Europe. DRP-Classification V6.2. http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf (accessed 13 August 2014).
17. AbuRuz SM, Bulatova NR, Yousef AM,. Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci, 2006; 28: 222-232.
18. Conort O, Bedouch P, Juste M, Augereau L, Charpiat B, Roubille R, Allenet B,. Validation d'un outil de codification des interventions de pharmacie clinique. J Pharm Clin, 2004; 23: 141-147.
19. Allenet B, Bedouch P, Rose FX, et al,. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci, 2006; 28: 181-188.
20. Bedouch P, Charpiat B, Roubille R, et al,. Site internet de la société française de pharmacie clinique pour l'analyse des interventions pharmaceutiques: finalité, mode d'emploi et perspectives. J Pharm Clin, 2007; 26: 40-44.
21. Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, Pamer C,. Retrospective analysis of mortalities associated with medications errors. Am J Health Syst Pharm, 2001; 58: 1835-1841.
22. Miremont-Salame G, Bernard-Laribiere A, Perault-Pochat M, Imbs J, Haramburu F,. French Pharmacovigilance. Hospital Admissions due to Adverse Drug Reactions: EMIR, a Nationwide Study. Drug Saf, 2008; 31: 885-960.
23. Charpiat B, Allenet B, Roubille R, et al,. Facteurs à prendre en considération pour la gestion des interactions médicamenteuses en pratique clinique. La Presse Médic, 2008; 37: 654-664.
24. Jacobson JO, Polovich M, Gilmore TR, Schulmeister L, Esper P, Lefebvre KB, Neuss MN,. Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: expanding the scope to include inpatient settings. Oncol Nurs Forum, 2012; 39: 31-38.
25. Schwappach DL, Wernli M,. Chemotherapy patients' perceptions of drug administration safety. J Clin Oncol, 2010; 28: 2896-2901.
26. Ranchon F, Salles G, Späth HM, et al,. Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs. BMC Cancer, 2011; 11: 478.
27. Ranchon F, Moch C, You B, et al,. Predictors of prescription errors involving anticancer chemotherapy agents. Eur J Cancer, 2012; 48: 1192-1199.
28. Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, Carey DL,. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol, 2004; 57: 513-521.
29. Arques-Armoiry E, Cabelguenne D, Stamm C, et al,. Problèmes médicamenteux les plus fréquemment détectés par l'analyse pharmacothérapeutique des prescriptions dans un centre hospitalier universitaire. Rev Med Interne, 2010; 30: 804-811.
30. Klys M, Konopka T, Scislowski M, Kowalski P,. Fatality involving vinblastine overdose as a result of a complex medical error. Cancer Chemother Pharmacol, 2007; 59: 89-95.
31. Ferayan A, Russell NA, Al Wohaibi M, Awada A, Scherman B,. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection. Childs Nerv Syst, 1999; 15: 87-89.
32. Ettinger LJ,. Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdose. Cancer, 1982; 50: 444-450.
33. Chu G, Mantin R, Shen YM, Baskett G, Sussman H,. Massive cisplatin overdose by accidental substitution for carboplatin. Cancer, 1993; 72: 3707-3714.
34. Tournel G, Bécart-Robert A, Courtin P, Hédouin V, Gosset D,. Fatal accidental intrathecal injection of vindesine. J Forensic Sci, 2006; 51: 1166-1168.
35. Dettmeyer R, Driever F, Becker A, Wiestler OD, Madea B,. Fatal myeloencephalopathy due to accidental intrathecal vincristine administration: a report of two cases. Forensic Sci Int, 2001; 122: 60-64.
36. Kwack EK, Kim DJ, Park TI, Cho KR, Kwon IH, Sohn YK,. Neural toxicity induced by accidental intrathecal vincristine administration. J Korean Med Sci, 1999; 14: 688-692.
37. Mortensen ME, Cecalupo AJ, Lo WD, Egorin MJ, Batley R,. Inadvertent intrathecal injection of daunorubicin with fatal outcome. Med Pediatr Oncol, 1992; 20: 249-253.
38. Rubin G, George A, Chinn DJ, Richardson C,. Errors in general practice: development of an error classification and pilot study of a method for detecting errors. Qual Saf Health Care, 2003; 12: 443-447.
39. Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M,. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer, 2009; 124: 722-728.
40. Petain A, Chatelut E,. Anticancer drug dose individualisation: from body surface area to physiology. Bull Cancer, 2008; 95: 895-901.
41. Nerich V, Borg C, Villanueva C, et al,. Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs. J Oncol Pharm Practice, 2013; 19: 8-17.
42. Ranchon F, You B, Salles G, et al,. Improving cancer patient care with combined medication error reviews and morbidity and mortality conferences. Chemotherapy, 2013; 59: 330-337.
43. Schmitt A, Gladieff L, Lansiaux A, et al,. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients. Clin Cancer Res, 2009; 15: 3633-3639.
44. Bedouch P, Charpiat B, Conort O, et al,. Assessment of clinical pharmacists' interventions, in French hospitals: results of a multicenter study. Ann Pharmacother, 2008; 42: 1095-1103.
45. Charpiat B, Goutelle S, Schoeffler M, et al,. Prescriptions analysis by clinical pharmacists in the post-operative period: a 4-year prospective study. Acta Anaesthesiol Scand, 2012; 56: 1047-1051.
46. Lenz HJ,. Management and preparedness for infusion and hypersensitivity reactions. Oncologist, 2007; 12: 601-609.
47. Ko Y, Tan SL, Chan A, et al,. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study. Clin Ther, 2012; 34: 1696-1704.
48. Smithburger PL, Buckley MS, Bejian S, Burenheide K, Kane-Gill SL,. A critical evaluation of clinical decision support for the detection of drug-drug interactions. Expert Opin Drug Saf, 2011; 10: 871-882.
49. Ranchon F, Vantard N, Gouraud A, et al,. Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report-should the practice be changed? Chemotherapy, 2011; 57: 225-229.
50. Reckmann MH, Westbrook JI, Koh Y, Lo C, Day RO,. Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc, 2009; 16: 613-623.
51. Nerich V, Limat S, Demarchi M, et al,. Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errors. Int J Med Inform, 2010; 79: 699-706.
52. Grangeasse L, Fagnoni-Legat C, Chaigneau L, et al,. Prescription informatisée et protocolisée des chimiothérapies: risque iatrogène résiduel et interventions pharmaceutiques. J Pharm Clin, 2006; 25: 33-38.
53. Charpiat B, Bedouch P, Conort O, Rose FX, Juste M, Roubille R, Allenet B,. Opportunities for medication errors and pharmacist's interventions in the context of computerized prescription order entry: a review of data published by French hospital pharmacists. Ann Pharm Fr, 2012; 70: 62-74.
54. Kushniruk AW, Bates DW, Bainbridge M, House MS, Borycki EM,. National efforts to improve health information system safety in Canada, the United States of America and England. Int J Med Inform, 2013; 82: 149-160.
55. Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL,. Role of computerized physician order entry systems in facilitating medication errors. JAMA, 2005; 293: 1197-1203.
56. Jeon J, Taneva S, Kukreti V, Trbovich P, Easty AC, Rossos PG, Cafazzo JA,. Toward successful migration to computerized physician order entry for chemotherapy. Curr Oncol, 2014; 21: 221-228.